SAN DIEGO--(BUSINESS WIRE)--Ichor Medical Systems (Ichor) of San Diego announced today that it has been selected to receive a $3.3 million grant award from the National Institute of Neurological Disorders and Stroke (NINDS) for development of a vaccine for Alzheimer’s disease. Ichor is collaborating on the project with Dr. Michael Agadjanyan, Vice President and Head of Immunology at the Institute for Molecular Medicine (IMM), Huntington Beach, CA; Dr. David H. Cribbs, Professor, Department of Neurology and Institute for Memory Impairments and Neurological Disorders at the University of California, Irvine (UCI); and Dr. Ruth Mulnard, Associate Professor of Neurology and Associate Director, Institute for Clinical Translational Science at UCI.